AccuStem Sciences, Inc.
ACUT
$0.5008
-$0.1702-25.37%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.50% | -53.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.97% | -47.17% | |||
| Operating Income | -17.97% | 47.17% | |||
| Income Before Tax | -17.97% | 47.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.97% | 47.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.97% | 47.17% | |||
| EBIT | -17.97% | 47.17% | |||
| EBITDA | -18.03% | 47.25% | |||
| EPS Basic | -17.96% | 47.20% | |||
| Normalized Basic EPS | -18.30% | 47.24% | |||
| EPS Diluted | -17.96% | 47.20% | |||
| Normalized Diluted EPS | -18.30% | 47.24% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
